Showing results (1161-1170 of 1,370) with videos related to
Sort By:
Pageof 137
Pharmacogenomics|June 23, 2017
Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experienceCarolyn R Rohrer Vitek, Noura S Abul-Husn, John J Connolly, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2020
The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitorsBin Zhu, Peter J Connolly, Yue-Mei Zhang, et al.International Journal of Stroke : Official Journal of the International Stroke Society|December 19, 2019
Semi-automatic measurement of intracranial hemorrhage growth on non-contrast CTKevin J Chung, Hulin Kuang, Alyssa Federico, et al.Journal of the American Heart Association|December 21, 2018
Statins Reduce Thoracic Aortic Aneurysm Growth in Marfan Syndrome Mice via Inhibition of the Ras-Induced ERK (Extracellular Signal-Regulated Kinase) Signaling PathwayTetsuya Sato, Mamoru Arakawa, Yasushi Tashima, et al.Journal of Cardiovascular Electrophysiology|April 5, 2019
Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE studyJörg Neuzner, Stefan H Hohnloser, Valentina Kutyifa, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 8, 2018
Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE studyRoopinder K Sandhu, Kenneth K Quadros, Yan Yun Liu, et al.Bioorganic & Medicinal Chemistry Letters|July 26, 2008
4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitorsGuozhang Xu, Marta C Abad, Peter J Connolly, et al.American Heart Journal|June 20, 2017
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trialRenato D Lopes, Marco Alings, Stuart J Connolly, et al.Journal of Thrombosis and Haemostasis : JTH|June 9, 2020
Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trialsJulia Aulin, Ziad Hijazi, Agneta Siegbahn, et al.Journal of Personalized Medicine|November 24, 2022
Outcomes of Returning Medically Actionable Genomic Results in Pediatric ResearchAmy A Blumling, Cynthia A Prows, Margaret H Harr, et al.Pageof 137